Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prognostic significance of the triple negative phenotype in endometrial cancer.

Gynecologic oncology - 1 Aug 2010

Kothari Rajul, Morrison Carl, Richardson Debra, Seward Shelly, O'Malley David, Copeland Larry, Fowler Jeffrey, Cohn David E

Abstract excerpt

OBJECTIVE: To determine if the triple negative phenotype (TNP) has prognostic significance in endometrial cancer with respect to various surgicopathologic outcomes and survival. METHODS: A tissue microarray was constructed of 396 endometrial cancers from patients who underwent surgical staging at the Ohio State University Medical Center. Immunohistochemistry was used to test for estrogen receptor, progesterone...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Endometrial Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to In Situ Hybridization, Fluorescence

Share to Proportional Hazards Models

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Share to Survival Rate

Source

Identifiers

PMID: 20605625
DOI: 10.1016/j.ygyno.2010.04.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prognostic significance of the triple negative phenotype in endometrial cancer.PMID 20605625Read ↗

Triple negative endometrial cancer.Semantic proximity Read ↗

Impact of TP53 somatic mutations on prognosis in endometrial cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

'Triple negative' epithelial ovarian cancer and pathologic markers for prognosis.Semantic proximity Read ↗

TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes.Semantic proximity Read ↗

Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative.Semantic proximity Read ↗

Impact of triple negative phenotype on breast cancer prognosis.Semantic proximity Read ↗

p53 overexpression as a prognostic indicator in endometrial carcinoma.Semantic proximity Read ↗

p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review.Semantic proximity Read ↗

Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancerSemantic proximity Read ↗

p53 Immunohistochemical Staining and TP53 Gene Mutations in Endometrial Cancer: Does Null Pattern Correlate With Prognosis?Semantic proximity Read ↗

DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancerSemantic proximity Read ↗

HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.